생식세포난소종양 (Ovarian Germ Cell Tumors)의 최신 처치 지견

Abstract

Significant improvements in the management of ovarian germ-cell tumors have been achieved during the past two decades. The development of more effective chemotherapeutic regimens is clearly the leading cause for improved outcome for these patients. In addition, advancements in other disciplines led to the development of a more precise surgical staging system, improved radiographic imaging, more sophisticated pathology techniques, as well as improved supportive care and symptom control. A substantial majority of patients with ovarian germ-cell tumors are long term survivals and suffer minimal morbidity from treatment. Fertility-sparing surgical procedures enable a large proportion of young women with ovarian germ-cell tumors to preserve their reproductive potential.